The forecast data for malignant neoplasms mortality in Finland, expressed in standardized rates of female deaths per hundred thousand women, shows a gradual decline from 2024 to 2028. The mortality rate is expected to decrease from 147.1 in 2024 to 144.5 in 2028. This declining trend indicates an annual reduction, reflecting advancements in healthcare, early detection, and improved treatments for malignant neoplasms.
Key variations:
- 2024 to 2025: -0.41%
- 2025 to 2026: -0.48%
- 2026 to 2027: -0.48%
- 2027 to 2028: -0.41%
The compound annual growth rate (CAGR) from 2024 to 2028 is approximately -0.44%, indicating a steady year-on-year decline.
Future trends to watch for include the impact of new cancer treatments, public health initiatives aimed at cancer prevention, and advancements in genomic medicine. Increased awareness and early detection campaigns could further accelerate the reduction in mortality rates.
